Altasciences Company Inc.
Laval, Quebec, Canada
Purpose
to fund the execution of multiple open-label single dose crossover bioequivalence studies in healthy volunteers comparing Biltricide® 600 milligram tablet to 600 milligram Praziquantel generic tablets
Division
Global Health, Global Policy and Advocacy
Date
November 2017
Region Served
GLOBAL
Committed amount
$716,876
Grant topic
Global Health and Development Public Awareness and Analysis, Neglected Tropical Diseases
Duration (months)
31
Grantee location
Laval, Quebec, Canada
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.